KRON Insider Trading
Insider Ownership Percentage: 24.40%
Insider Buying (Last 12 Months): $2,787,697.16
Insider Selling (Last 12 Months): $0.00
Kronos Bio Share Price & Price History
Current Price: $0.82
Price Change: ▼ Price Decrease of -0.007 (-0.85%)
As of 04/1/2025 03:29 PM ET
Kronos Bio Insider Trading History
Kronos Bio Institutional Trading History
Data available starting January 2016
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of therapeutics for various cancer and other serious diseases in the United States. Its lead product candidates are KB-0742, an oral cyclin dependent kinase 9 inhibitor for the treatment of MYC-amplified solid tumors, which is in phase 2 clinical trial; and KB-9558, a core oncogenic transcription factor that drives multiple myeloma. The company was incorporated in 2017 and is headquartered in San Mateo, California.
Read More on Kronos Bio
Volume
58,451 shs
Average Volume
269,752 shs
Market Capitalization
$49.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.79
Who are the company insiders with the largest holdings of Kronos Bio?